TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA) 04641655190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-07-17 for TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA) 04641655190 manufactured by Roche Diagnostics.

Event Text Entries

[114689829] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[114689830] The customer complained of an erroneous low result for 1 patient sample tested for elecsys total psa immunoassay (total psa) on a cobas e 411 immunoassay analyzer. The initial total psa result was 0. 02 ng/ml with a data flag. The free psa result was 0. 170 ng/ml. These results were reported outside of the laboratory where the doctor requested repeat testing. The customer stated the last time calibration was performed was on (b)(6) 2018 and the customer is only running one level of qc. The customer recalibrated the total psa reagent and repeated the test. On (b)(6) 2018 the sample was repeated and the total psa result was 0. 347 ng/ml and the free psa result was 0. 191 ng/ml. There was no allegation that an adverse event occurred. The total psa reagent lot number was 29152806 with an expiration date of 31-mar-2019. The customer's calibration signals from 11-jun-2018 were higher than expected for cal1 and lower than expected for cal2. After the customer re-calibrated, the signals for cal1 were ok but the cal 2 signals were still lower than expected. Qc level 1 from (b)(6) 2018 and (b)(6) 2018 were within the specified ranges. Qc level 2 from (b)(6) 2018 and (b)(6) 2018 were within the specified ranges. Product labeling states that qc should be run at least every 24 hours when the test is in use, once per reagent kit and following each calibration. No issues were identified during a review of the customer's alarm trace data. No issues were noted with the customer's pre-analytical data. The field service engineer (fse) visited the customer site and advised the customer about the importance of running both levels of qc and performing calibration at the appropriate intervals. Based on the data provided, an assay related issue is not suspected. A general product problem can be excluded. The investigation was unable to determine a definitive root cause.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2018-02369
MDR Report Key7694525
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-07-17
Date of Report2018-07-17
Date of Event2018-07-02
Date Mfgr Received2018-07-03
Date Added to Maude2018-07-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA)
Generic NameTOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS
Product CodeMTF
Date Received2018-07-17
Model NumberNA
Catalog Number04641655190
Lot Number29152806
Device Expiration Date2019-03-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-07-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.